Business Description
CervoMed Inc
NAICS : 325414
SIC : 2834
ISIN : US2537482067
Description
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.67 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 66.7 | |||||
| 3-Year EPS without NRI Growth Rate | 66.8 | |||||
| 3-Year FCF Growth Rate | 47.1 | |||||
| 3-Year Book Growth Rate | -64.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 72.53 | |||||
| 12-1 Month Momentum % | -2.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.99 | |||||
| Quick Ratio | 2.99 | |||||
| Cash Ratio | 2.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -88 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -45.83 | |||||
| ROA % | -37.74 | |||||
| ROIC % | -1386.77 | |||||
| ROCE % | -41.69 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 22.82 | |||||
| Price-to-Tangible-Book | 22.83 | |||||
| EV-to-EBIT | -35.05 | |||||
| EV-to-EBITDA | -35.05 | |||||
| EV-to-FCF | -21.18 | |||||
| Price-to-Net-Current-Asset-Value | 22.83 | |||||
| Price-to-Net-Cash | 32.81 | |||||
| Earnings Yield (Greenblatt) % | -2.85 | |||||
| FCF Yield % | -4.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CervoMed Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -2.855 | ||
| Beta | 0.26 | ||
| Volatility % | 32.8 | ||
| 14-Day RSI | 72.53 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 5.25 | ||
| 12-1 Month Momentum % | -2.23 | ||
| 52-Week Range (€) | 3.719999 - 5.879999 | ||
| Shares Outstanding (Mil) | 8.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CervoMed Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CervoMed Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
CervoMed Inc Frequently Asked Questions
What is CervoMed Inc(STU:DP8)'s stock price today?
The current price of STU:DP8 is €5.25. The 52 week high of STU:DP8 is €5.88 and 52 week low is €3.72.
When is next earnings date of CervoMed Inc(STU:DP8)?
The next earnings date of CervoMed Inc(STU:DP8) is 2024-08-15 Est..
Does CervoMed Inc(STU:DP8) pay dividends? If so, how much?
CervoMed Inc(STU:DP8) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers